Company Performance - Village Farms International, Inc. remains a top three cannabis producer in Canada and was the second fastest growing producer organically year-over-year[393]. - Sales for the year ended December 31, 2024 increased by 50,578,orapproximately18336,181 compared to 285,603for2023[400].−SalesforVFFreshreached169,183, while Cannabis Canada and U.S. Cannabis generated 148,856and17,390 respectively, totaling 336,181fortheyearendedDecember31,2024[429].−CanadiancannabisnetsalesfortheyearendedDecember31,2024increasedby34,826, or 31%, to 148,856from114,030 in 2023[432]. - U.S. Cannabis net sales for the year ended December 31, 2024, decreased by 14% to 17,390from20,330 in 2023, attributed to new restrictions on CBD sales[457]. - Produce sales for the year ended December 31, 2024, increased by 12% to 169,184comparedto151,243 in 2023, driven by a 13% increase in pounds sold[471]. Financial Results - The net loss for the year ended December 31, 2024 was 3,181,comparedtonetincomeof2,936 in 2023, primarily due to an inventory write-down of 10,436(C15,000)[443]. - Adjusted EBITDA for 2024 decreased by 5,797to1,788 from 7,585in2023[413].−ThenetlossattributabletoVillageFarmsInternational,Inc.shareholdersfor2024was35,850, an increase of 1,052,or334,798 in 2023[412]. - Loss before taxes and loss from equity method investments for 2024 was 37,305,anincreaseof9,937, or 36%, compared to 27,368in2023[409].−AdjustedEBITDAfortheyearendedDecember31,2024was7,282, a decrease of 7,482,or5114,764 in 2023, largely due to the inventory impairment charge[445]. Cost and Expenses - Cost of sales for 2024 increased by 52,604,or22288,781 from 236,177in2023[401].−Selling,generalandadministrativeexpensesfor2024increasedby5,547 to 71,048,or2165,501, or 23% of sales, in 2023[403]. - Gross margin for 2024 decreased by 2,026,or447,400 from 49,426in2023[402].−Thecompanyincurredexcisetaxof71,953 (C98,442)fortheyearendedDecember31,2024,anincreaseof13,938 (C20,127),or2458,015 (C78,315)in2023[433].ImpairmentsandWrite−downs−Goodwillandintangibleassetimpairmentsfor2024were11,939 compared to 14,020in2023[408].−Inventorywrite−downsfortheyearendedDecember31,2024,were11,038 due to older manufactured products requiring higher rework costs than their resale value[537]. - The company reported impairments of 10,039,000forgoodwilland1,900,000 for intangible assets in 2024, compared to 11,300,000and2,720,000 respectively in 2023[514]. Market and Operational Challenges - The company continues to face challenges from unregulated hemp-derived products in the U.S. market, which may impact market share for the CBD industry[393]. - The company is exploring options to sell its Produce assets and has an ongoing sale process for its Monahans greenhouse facility[393]. - The company has material long-term debt and lines of credit that may be affected by rising interest rates, impacting the cost of capital[506]. Strategic Initiatives - The acquisition of Leli Holland was completed in Q4 2024, making it a wholly owned subsidiary, with sales expected to commence in February 2025[386]. - The company plans to continue focusing on market expansion and new product development to drive future growth[429]. - The company plans to consolidate its financial results with a 100% interest in Leli beginning on September 23, 2024[514]. Cash Flow and Liquidity - Cash and cash equivalents as of December 31, 2024 were 24,631,downfrom35,291 as of December 31, 2023[485]. - Operating activities generated cash flow of 10,348fortheyearendedDecember31,2024,comparedto5,315 for the year ended December 31, 2023[502]. - Cash flows used in investing activities for 2024 were 10,241million,upfrom6,231 million in 2023 and down from 20,889millionin2022,primarilydueto6,061 million in capital expenditures for Leli and $4,022 million for cannabis operations[503].